Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease
Details for Australian Patent Application No. 2005227931 (hide)
International Classifications
Event Publications
26 October 2006 PCT application entered the National Phase
PCT publication WO2005/095324 Priority application(s): WO2005/095324
4 October 2007 Assignment before Grant
Dainippon Ink and Chemicals, Inc. The application has been assigned to Activus Pharma Co., Ltd
24 June 2010 Application Accepted
Published as AU-B-2005227931
21 October 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser